MindMaze Therapeutics to Present at Investor Conferences
MindMaze Therapeutics Holding SA announced its participation in upcoming investor and industry conferences in the United States. The company will present its advancements in neurotherapeutic solutions.
MindMaze Therapeutics Holding SA (SIX: MMTX) has announced its participation in several upcoming investor and industry conferences in the United States. These events provide a platform for the company to showcase its progress in the field of neurotherapeutic solutions.
The company is scheduled to present at the Morgan Stanley Global Healthcare Conference in New York on September 14. Following this, MindMaze Therapeutics will present at the Cantor Fitzgerald Global Healthcare Conference in San Francisco on September 23.
MindMaze focuses on developing scalable, precision neurotherapeutics aimed at improving patient recovery from neurological conditions and injuries. Their technology seeks to enhance rehabilitation processes.
Participation in these conferences is part of the company's strategy to increase visibility and share updates on its development efforts with investors and industry professionals. MindMaze Therapeutics is listed on the SIX Swiss Exchange under the ticker MMTX.